Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses
about
A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphateIn vitro activities of methylenecyclopropane analogues of nucleosides and their phosphoralaninate prodrugs against cytomegalovirus and other herpesvirus infectionsEffect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infectionPyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirusEffect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongationIdentification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition.Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.Cytomegalovirus infection and cardiac allograft vasculopathy.Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymeraseMetabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells.A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives.Antiviral therapy: current concepts and practicesHuman cytomegalovirus induces JC virus DNA replication in human fibroblasts.Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections.Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay.Antiviral guanosine analogs as substrates for deoxyguanosine kinase: implications for chemotherapy.Effect of duration and intensity of ganciclovir exposure on lymphoblastoid cell toxicity.Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir.Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures.Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97.Identification of a critical window for ganciclovir-induced disruption of testicular development in rats.Ganciclovir Treatment of Congenital Cytomegalovirus Infection: A report of two cases
P2860
Q24628878-30C318A8-04EB-48DF-A3C8-EC3B7B5E829CQ28344285-EF1226B8-A635-45DD-93BD-23FF1EAE3054Q28354236-5535E99B-B08F-4851-BC2B-D4CBF13D5192Q28360591-C7C8818F-FB56-448D-92F6-8B1CB06F240EQ28379498-9A7B72CB-B7EE-4338-B9B7-7B8CCEA1B4B3Q33646854-B113670F-B52A-4983-B6BF-A8A389F4CCD9Q33982065-871F0875-6307-4177-9138-A4DC86D1562FQ34294809-5C7A9A0E-1AA5-4A1F-BCB3-224059919DA7Q34922240-A2408C4F-6B41-4EE4-9C85-87B6FE84AAABQ35139402-1099207B-B42C-4D64-82FB-92A024BCDC94Q35574358-889F41A7-5D39-468A-B4B4-0FC22F3D95E5Q35807437-BCECA622-E6B2-4040-B5FC-9700C1E7CD07Q36070394-10436C37-8754-455A-99AE-3D83F2E8021CQ36704007-37EEF9E4-6118-4FCD-9CA8-1CBB715F49EEQ37570464-EFFAC2E4-B166-46A9-B5B2-A436D085358AQ38271850-E60B59E0-51B2-4F45-8870-BF2B89A77C0EQ38305554-6F5F49BD-CE41-48B8-9CA0-871518F11D98Q39003286-5FE1830D-429C-4CD8-B596-8F9909BEF36DQ39476520-AF9D46F2-CEA5-458F-8566-410D0B0253AAQ39819129-AF77E0E4-38FA-4AB5-B466-EBC2E4E10FB7Q39819956-778772A9-8AEF-46B3-A3E1-A2513B838A8FQ40087350-0B94CDA0-1339-480B-B228-4B32D1784560Q40215069-9AC943E0-5ECC-4B0C-B687-38DE3BB8A1EEQ40672683-330724DB-66C4-4DB8-8389-D15B046C6515Q42286758-E768DCDB-79D3-4452-85CA-019277A738EEQ49935276-8947961B-3FB6-4D60-A17E-BEB4EF134ABFQ57990475-74D46468-7471-49E7-9839-8164F6C4CB50
P2860
Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@ast
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@en
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@nl
type
label
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@ast
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@en
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@nl
prefLabel
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@ast
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@en
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@nl
P2093
P2860
P356
P1476
Activity of 9-(1,3-dihydroxy-2 ...... , and rodent cytomegaloviruses
@en
P2093
P2860
P356
10.1128/AAC.28.2.240
P407
P577
1985-08-01T00:00:00Z